Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron for Cold Tolerance in Navy Divers
NCT04766021Phase 2Completed
- Sponsor
- Indiana University
- Start
- Nov 2021
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mirabegron in Hypothermia, sponsored by Indiana University. Started Nov 2021; status: completed.
02
Drugs
mirabegron
03
Conditions
Hypothermia
Beyond the preview
Go deeper on NCT04766021.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04766021.